| MDL | - |
|---|---|
| Molecular Weight | 451.35 |
| Molecular Formula | C21H24Cl2N4O3 |
| SMILES | NC(C(C=C1)=CC=C1CNC(NC[C@H](OCC2)CN2CC3=CC(Cl)=C(Cl)C=C3)=O)=O |
|
CCR3 7.86 (pKi) |
GW 766994 is a specific chemokine receptor-3 (CCR3) antagonist, which has entered clinical trial for asthma and eosinophilic bronchitis [1] . GW 766994 (10 μM) reverses CCL11-induced activation of CDK5, phosphorylations of CDK5, GSK3β, and increased phosphorylation of tau in hippocampal neurons [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 56 mg/mL ( 124.07 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.2156 mL | 11.0779 mL | 22.1558 mL |
| 5 mM | 0.4431 mL | 2.2156 mL | 4.4312 mL |
| 10 mM | 0.2216 mL | 1.1078 mL | 2.2156 mL |